A Dubai deep-tech company just raised $40 million to merge three working prototypes into a single smart lens. Whether it can avoid the fate of earlier pioneers remains an open question.
---
In a gleaming lab tucked into Dubai's tech corridors, a team of physicists has been quietly building something that sounds ripped from a sci-fi screenplay: contact lenses that overlay digital information onto the real world, see in the dark with zoom capabilities, and monitor your health—all at once.
XPANCEO, the deep-tech startup behind the effort, closed a $40 million seed round on October 16, 2023, led by Opportunity Venture (Asia) Limited, a Hong Kong investment firm with a portfolio spanning Asia, Europe, and the Middle East, alongside other investors. It's the kind of bet that signals either supreme confidence or a technology too specialized for a traditional syndicate. Perhaps both.
Founded in 2021 by entrepreneur Roman Axelrod and physicist Dr. Valentyn S. Volkov, XPANCEO bootstrapped its early days before relocating to Dubai and assembling a team that now stands at approximately 100 people, with around 80 working in R&D—about half of whom hold PhDs. By the time the seed money arrived, the company had already showcased 28 advanced prototypes demonstrating capabilities spanning AR vision, health monitoring, an integrated microbattery, wireless data and power transfer, color correction for people with color blindness, and other cutting-edge technologies—a rare feat in a field littered with abandoned projects and technical dead ends.
An Expanding Vision
The prototypes span augmented reality and holographic displays, night vision and 3D imaging, biometric monitoring, and much more. XPANCEO's endgame? Unify health monitoring, AR vision features, and wireless power transfer into what it describes as "the ultimate interface for AI-powered XR computing"—with a working all-in-one prototype targeted by the end of 2026.
It's a bold claim in an industry where even incremental progress often stalls. The technical approach diverges from conventional wisdom: instead of relying on traditional silicon, XPANCEO uses 2D materials and optoelectronics, aiming for lenses that are genuinely invisible and weightless when worn. The company currently has 20+ patent-pending applications—a signal that it's building something defensible, or at least trying to.
Philip Ma, Managing Director at Opportunity Venture (Asia), visited XPANCEO's Dubai facility in January 2024, a few months after wiring the funds. "We are backing XPANCEO for their capacity to deliver on their product vision," Ma said, noting the startup's potential to define the next wave of personal computing. Whether that proves prescient or optimistic depends largely on whether the technology can escape the lab.
The $40 Million Roadmap
The capital infusion will fund the consolidation effort—merging those prototype capabilities into a single, functioning device. The money is also accelerating iterations on the AR-vision lens, which may be the most commercially viable piece of the puzzle in the near term.
For context, The National reported XPANCEO's seed round as the second-largest in the Middle East and North Africa that year, and Eqvista pegged it as the 24th-biggest globally in 2023. Not bad for a company that had been self-funded just months earlier.
A Graveyard of Good Intentions
The smart contact lens space has humbled more than a few well-funded ventures. Mojo Vision, once considered a frontrunner, pivoted away from AR contact lenses in January 2023 after slashing 75% of its workforce—a stark reminder that hardware innovation at this scale is unforgiving. Verily, Alphabet's life sciences arm, abandoned its glucose-sensing smart lens project in 2018, citing insurmountable challenges with tear-based sensing accuracy.
These aren't fringe startups. They were serious players with deep pockets and world-class engineering talent. Their struggles underscore the razor-thin margin between breakthrough and breakdown in this category.
Yet XPANCEO appears undeterred. In July 2025, Opportunity Venture (Asia) doubled down, leading a $250 million Series A that valued the company at $1.35 billion. That's unicorn territory—and a remarkable vote of confidence for a startup that hadn't yet shipped a commercial product.
What Comes Next
XPANCEO's trajectory raises familiar questions. Can the technology scale beyond the lab? Will regulatory bodies approve lenses that interface with digital systems and collect biometric data? And perhaps most importantly: is there genuine consumer appetite for smart contact lenses, or is this a solution still searching for a mass-market problem?
The answers won't arrive until 2026 at the earliest. Until then, XPANCEO remains a high-stakes experiment in a field where failure is common and success would be transformative. For now, it has capital, momentum, and a lab full of scientists convinced they're building the future. Whether the rest of us will wear it on our eyes is another matter entirely.
